Menu

能倍乐噻托溴铵喷雾剂的效果

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Effects of Tiotropium Bromide Spray: Respimat contains two active substances, tiotropium bromide and olodaterol, both of which are long-acting bronchodilators. Respimat helps adults with chronic obstructive pulmonary disease (COPD) breathe easier. COPD is a long-term lung disease that causes shortness of breath and coughing. Respimat helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

The effect of Respimat lasts for 24 hours, so it only needs to be used once a day. It is best to use it at the same time every day. Spray twice and do not overdose. Respimat cannot be frozen and the inhaler should be discarded within 3 months of first use. Since COPD is a long-term disease, use Respimat every day, not just when you have breathing problems.

In a research trial, 298 patients with chronic obstructive pulmonary disease were included and randomly divided into an observation group (149 cases) and a control group (149 cases). The observation group was treated with Slivar (Rebena Tiotropium Bromide Spray) for 3 months, and the control group was treated with aminophylline for 3 months. The results showed that the lung function index of patients treated with Slihua was significantly better than that of the control group, and the difference was statistically significant. In terms of the incidence rate of adverse reactions, the incidence rate in the Slihua treatment group was 3.3% and that in the control group was 10.7%. The difference between the two groups was statistically significant. Patients' use of Siliva treatment can effectively improve lung function indicators with remarkable results.

The above is the effect of tiotropium bromide spray. Patients must use the medication correctly and actively cooperate with the treatment during the treatment period.

Recommended related hot articles: /newsDetail/82347.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。